GALNF — Stock activity · TradeandTellGALN
GALNF
$115.00-$1.19 (-1.02%)prev close
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$105.00 – $116.19
89% from low
Held by traders on TradeandTell
No one on the platform currently holds GALNF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in GALNF as of their last filing.
Insider activity (SEC Form 4)
Dividend history
TTM yield · 4.17% ($4.80/share)
| Ex-date | Per share | Pay date |
|---|
| 2026-04-24 | $1.2500 | 2026-04-27 |
| 2026-04-24 | $1.2500 | 2026-04-27 |
| 2025-04-15 | $1.1500 | 2025-04-16 |
| 2025-04-14 | $1.1500 | 2025-04-16 |
| 2024-04-12 | $1.1000 | 2024-04-16 |
Recent trades on TradeandTell
No one on the platform has traded GALNF yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
$GALNF chatter on StockTwits
Galenica upgraded by UBS Group AG to buy. www.marketbeat.com/stocks/OTCMKTS/GALNF/price-target/ $GALNF
View on StockTwits ↗Galenica upgraded by Deutsche Bank Aktiengesellschaft to hold. www.marketbeat.com/stocks/OTCMKTS/GALNF/price-target/ $GALNF
View on StockTwits ↗Galenica downgraded by Deutsche Bank Aktiengesellschaft to sell. https://www.marketbeat.com/r/1813397 $GALNF
View on StockTwits ↗Galenica downgraded by Credit Suisse Group AG to underperform. https://www.marketbeat.com/r/1797133 $GALNF
View on StockTwits ↗
Jack@TradeMasterJackJul 27 $GALNF ↓downgrade Galenica downgraded to Underperform from Neutral at Credit Suisse
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2026 | $4.3B | +4.2% | $3.89 | $3.77–$3.94 | 29.6× | 1 |
| 2027 | $4.5B | +3.7% | $4.21 | $4.08–$4.26 | 27.3× | 1 |
| 2028 | $4.6B | +3.2% | $4.46 | $4.33–$4.52 | 25.8× | 1 |
| 2029 | $4.8B | +4.3% | $4.76 | $4.62–$4.82 | 24.2× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Earnings surprises
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|
| 2026-08-06 | $2.39 | $2.26 | -5.4% |
| 2026-03-10 | $2.51 | $2.35 | -6.4% |
| 2025-08-07 | $2.21 | $2.28 | +3.2% |
| 2025-03-11 | $2.01 | $2.01 | +0.0% |
| 2024-08-06 | $1.88 | $1.72 | -8.5% |
| 2024-03-12 | $1.97 | $2.30 | +16.8% |
| 2023-08-08 | $1.74 | $1.66 | -4.6% |
| 2023-03-07 | $1.75 |
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| GALNFGalenica AG | $115.00 | +0.00% | $5.7B | — |
| ANHGYMediclinic International plc | $5.49 | +0.00% | $4.0B | — |
| ARHCFAlfresa Holdings Corporation | $14.00 | +0.00% | $2.5B | — |
| ASPHFAscentage Pharma Group International | $4.53 | +0.00% | $1.7B | — |
| CAKFYMcKesson Europe AG | $4.10 |
| INVVYIndivior PLC | $21.85 | +0.00% | $3.0B | — |
| IZQVFIndivior PLC | $20.97 | +0.00% | $2.9B | — |
Source: Financial Modeling Prep · peers by sector/industry